Mar 24, 2026 12:58PM
Mar 4, 2026 06:44AM
Aug 18, 2025 08:10AM
Aug 13, 2025 09:30AM
Jun 23, 2025 08:03AM
Jun 5, 2025 08:04AM
Jun 5, 2025 08:03AM NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Abbreviated New Drug Application (ANDA) for Preservative-Free IV Ketamine
May 15, 2025 04:03PM
Apr 30, 2025 08:46AM
Mar 20, 2025 06:44AM
Mar 17, 2025 08:02AM
Nov 14, 2024 04:05PM
Jul 29, 2024 08:36AM
Jul 29, 2024 08:35AM HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Alignment with FDA on Pediatric Study Plan for NRX-100 (ketamine)
Mar 28, 2024 08:04AM
Mar 28, 2024 08:03AM
Nov 13, 2023 06:39PM
May 26, 2022 07:20AM
Apr 22, 2022 01:25AM
Apr 1, 2022 01:30AM
Mar 31, 2022 01:30AM Relief Reports Full-Year 2021 Results and Provides Corporate Update

15,434 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All